Artificial intelligence (AI) and "protein language" models can speed the design of monoclonal antibodies that prevent or ...

Artificial intelligence (AI) and "protein language" models can speed the design of monoclonal antibodies that prevent or ...

Artificial intelligence (AI) and "protein language" models can speed the design of monoclonal antibodies that prevent or ...

Researchers are increasingly developing antibody therapies to treat infectious diseases. Therapies are being designed to ...

Doctors say a new antibody treatment and maternal vaccine could reduce RSV-related hospitalizations in infants.

The TL1a inhibitor duvakitug was effective at 14 weeks in patients who had previous exposure to conventional and advanced ...

The Indian Council of Medical Research (ICMR) has invited Expressions of Interest (EoI) for developing and manufacturing monoclonal antibodies against the Nipah virus, aiming to strengthen India’s ...

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I(TM)), today announced an evaluation and license agreement with Umoja Biopharma ("Umoja"), the ...

The trial was halted due to inadequate efficacy, Jay Bradner, M.D., Amgen’s executive vice president of R&D, said during a Nov. 4 call with investors, after an ad hoc analysis requested by an internal ...

Topline phase 3 results show that the novel nanobody gefurulimab is safe and effective for AChR-antibody-positive myasthenia ...

The global veterinary monoclonal antibodies market is set to surge, reaching USD 3.06 billion by 2030, up from USD 1.70 ...